28 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/28/3069677/0/en/ORIC-Pharmaceuticals-Presents-Preclinical-Data-to-Support-the-Potential-of-ORIC-944-as-a-Best-in-Class-PRC2-Inhibitor-for-the-Treatment-of-Prostate-Cancer-at-the-2025-American-Asso.html